Sirnaomics lands $105m Series E

Sirnaomics Ltd., a biopharmaceutical company, has secured $105 million in Series E financing.

Sirnaomics Ltd., a biopharmaceutical company, has secured $105 million in Series E financing. Rotating Boulder Fund led the round.

Source: Press Release